The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Inhaler Advantages. Portability: Inhalers are small, portable, and easy to carry, making them convenient for on-the-go asthma management. Faster Onset: Inhalers deliver medication quickly to the lungs ...